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Background: The effectiveness of health care and health policy developments are often determined by health-related quality of life (HRQOL) assessment.
Objectives: The objective of this study was to explore the potential corresponding factors and traditional biomarkers of HRQOL in a large number of Iranian hemodialysis patients.
Patients and Methods: A total of 6,930 chronic hemodialysis (HD) patients enrolled. KDCS-SF version 1.3 questionnaire was used to assess the health related quality of life (HRQOL). We pooled PCS, MCS and KDCS scores with random effect model from 19 similar studies performed between 1996 and 2010
Results: The mean age was 54.4 ± 17.1 years. Mean PCS, MCS and KDCS scores obtained for the study cohort were 40.79 ± 20.10, 47.79 ± 18.31 and 57.97 ± 11.70, respectively; the total score of SF-36 plus KDCS was 51.12 ± 13.41 as well. The most common primary known disease was hypertension (31.9%) and the second etiology was diabetes (25.5%). In multilevel logistic regression, Kt/V between 1 and 1.2 and PCS, KDCS more than 50 were considered as a significant reduction in the risk of hospitalization.
Conclusions: This study showed that PCS and MCS score were slightly more than overall results while KDCS was slightly less than overall results. In addition, dialysis adequacy with Kt/V between 1 and 1.2 is associated with lower rate of hospitalization.
Keywords: Quality of Life; Renal Dialysis; Mental Status Schedule; Kidney Diseases
Implication for health policy/practice/research/medical education:In HD patients, HRQOL may be affected by a number of variables, including the clinical manifestations of disease, the side effects of treatment, the quality of the social activities, nutritional status, hospitalization and etc. It is important to note that different races, cultural diversity and various ethnicities may play role in HRQOL among dialysis patients partly due to different perception of life and quality of their health care.Copyright © 2013, Nephrology and Urology Research Center; Licensee Kowsar Ltd. This is an Open Access article distributed under the terms of the Creative Com-mons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. BackgroundHemodialysis (HD) is a life-saving treatment for the pa-tients with end-stage renal disease (ESRD) requiring renal replacement therapy (1). the health-related quality of life (HRQOL) is lessened in patients with ESRD as expected in those with chronic illness (2), because these patients have many fears and various necessities (3). Therefore, to achieve a high-quality life is a difficult issue, and needs a close cooperation between nephrologists, psycholo-gists and social workers (4). The effectiveness of health care and development of health policies are often deter-mined by HRQOL assessments (5). HRQOL is also an im-
portant predictor of HD patients outcomes that should be frequently assessed (6). The world health organization (WHO) characterized health as attendance of physical, mental, and social well-being and is not limited to the absence of disease (7); hence, the HRQOL measurement indicates the impact of illness on the patient’s physical, mental, and social performance (1).Current studies (2, 7, 8) have publicized that a poor HRQOL in dialysis patients has strong correlation with increased rate of mortality. Thus, HRQOL is typically used to obtain information from patients, these information are not only focused on the health status, but also point-
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ing out the risk of important outcomes such as death (8).In HD patients, HRQOL may be affected by a number of elements, including clinical manifestations of disease, the treatment side effects, the quality of social activities, nutritional status, hospitalization (9), and some bio-chemical parameters such as Kt/V, calcium-phosphorus (Ca × P) product (1, 10), parathyroid hormone (PTH) levels (11, 12), anemia (9, 12-14), and serum albumin level (13, 15). It is important to note that different races, cultural diver-sity and various ethnicities may play role in HRQOL of di-alysis patients (16), partly due to different perception of life and quality of their health care (17).
2. ObjectivesThe objective of this study was to explore the potential corresponding factors and traditional biomarkers of HRQOL in a large number of Iranian HD patients which can help to modify the health care strategies.
3. Patients and Methods
3.1. PatientsThe Iranian adapted version of the kidney disease qual-ity of life short form version 1.3 (KDCS-SF1.3) question-naires was provided to all dialysis clinics in Iran with request for voluntary collaboration. A total of 6,930 chronic hemodialysis (HD) patients from 132 dialysis cen-ters participated in this cross-sectional study, from Octo-ber 2010 to August 2011. The patients 13 years old or older, with a clinically stable condition, with at least 3-month HD history, and receiving HD 3 times per week (each ses-sion lasts for 3 to 4 hours) were included in this study. The patients who were hospitalized for an acute illness, those with vascular access failure, including dialysis via a tem-porary vascular access and who refused to respond to the questionnaire were excluded.
3.2. Instruments KDCS-SF version 1.3 (18) questionnaire was used to as-sess health related quality of life (HRQOL). The KDCS-SF includes generic and disease specific cores. Generic core scales compromised of two components (mental and physical component summary, MCS and PCS), that including eight scales of the SF-36 physical functioning, role-physical, bodily pain, general health, vitality (ener-gy/fatigue), social functioning, mental health (emotional well-being), and role-emotion. Disease specific items contain eleven scales targeted on kidney diseases and including symptoms/problems, effects of kidney disease on daily life, burden of kidney diseases, work status, cog-nitive function, quality of social interaction, sexual func-tion, sleep, social support, dialysis staff encouragement, and patient satisfaction. These 11 kidney disease specific 
scales of KDCS-SF questionnaire validated in Iranian pa-tients condensed as kidney disease component summa-ry (KDCS). Each score is ranged from 0 to 100 point; so, higher scores indicated better life quality. The detailed translation and validation of SF-36 health survey have been described in another study (19); however, we have recently translated and validated KDCS-SF version 1.3 into Farsi (20). In this study, all scales internal consistency reli-ability measured according to Cronbach alphas ranging from 0.43 to 0.91 (Table 1). The questionnaire was general-ly self-administered, that the respondent fill out the form on his/her own; therefore, the patients mostly filled out their questionnaire at home or in dialysis department. The written information was double-checked with the pa-tients to assure correct understanding and to make sure that they completed the questionnaire properly. Based on previous studies, in this analysis we used the cut-off scores of 43 for PCS (3); 51 (3) and 43 (2) for MCS; and 50 for KDCS as critical scores (4), below which the score is considered inadequate.
3.3. Data AnalysisStatistical analyses were performed using SPSS 18.0 for windows. Clinical, demographic, and HRQOL variables were expressed as means and standard deviations. Cat-egorical variables were measured as frequencies and percentages. The one-way analysis of variance (ANOVA) or Kruskall-Wallis tests for skewed data used to compare continuous variables between more than two indepen-dent groups; the Student’s t-test or the Mann-Whitney test for skewed data was applied for comparisons be-tween two groups. The Chi square test was used to com-pare categorical variables. Pearson correlation was used to assess the relationship between quality of life and continuous variables (e.g., age, dialysis vintage, Kt/V, and Hb). Following univariate analysis, all demographic and clinical variables with P≤ 0.2 were entered as predictor variables in multiple regression models. A P-value of 0.05 or less was considered statistical significance.We used two-level logistic regression, patients as level 1 and hospital as level 2, to estimate associations between hospital-level factor and hospitalization outcomes. We also pooled PCS, MCS and KDCS scores using a random ef-fect model from 19 similar studies performed from 1996 to 2010 (Table 2). Then we compared our results with pooled data from all these studies. 
4. ResultsThe demographic features of the 6930 patients who formed this study group and responded to the question-naire are listed in Tables 3 and 4. The mean (+/-SD) age was 54.4 ± 17.1 years, with 1.3:1 male/female ratio, and a mean dialysis vintage of 37.5 ± 39.3 months. 
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Table 1. Mean and Standard Deviation, Variability and Reliability of KDQOL-SF and SF-36 Items 
Mean ± SD Cronbach’s alpha Floor, % Ceiling, %
Symptoms 67.9 ± 19.8 0.91 0.2 2.2
Effects of kidney 
disease
50.42 ± 20.9 0.79 1.4 0.6
Burden of kidney 
disease
23.08 ± 19.78 0.67 20.3 0.5
Work status 22.3 ± 34.56 0.43 62.3 11.3
Cognitive function 66.26 ± 21.21 0.63 2 8.01
Quality of social inter-
action
67.07 ± 20.08 0.49 0.2 7.1
Sexual function 63.48 ± 30.4 0.82 5.8 24.8
Sleep 55.9 ± 19.9 0.66 0.6 1.6
Social support 72.8 ± 26.9 0.78 3.04 34.3
Dialysis staff encour-
agement
81.3 ± 21.87 0.70 1.2 42.4
Patient satisfaction 69.01 ± 24.24 ---- 1.04 20.8
Kidney disease com-
ponent summary 
(KDCS)
57.97 ± 11.7 0.68 0 0.01
Physical function 40.46 ± 29.5 0.92 9.05 2.6
Rolephysical 25.6 ± 32.7 0.74 51.4 8.7
Pain 55.31 ± 25.73 0.82 0.1 10.3
General health 41.70 ± 19.71 0.62 1.8 0.4
Physical component 
summary (PCS)
40.79 ± 20.1 0.71 0 0.04
Emotional well-being 54.24 ± 18.03 0.64 0.4 1.2
Role emotional 36.28 ± 38.89 0.73 2 0.8
Social function 55.77 ± 22.3 0.43 45.3 18.7
Energy/ fatigue 44.76 ± 19.79 0.62 1.3 7.1
Mental component 
summary (MCS)
47.79 ± 18.31 0.65 0.07 0.3
SF-36 44.29 ± 17.7 0.82 0 0.01
SF-36 + KDCS 51.12 ± 13.41 0.74 0 0.01
Mean PCS, MCS and KDCS scores obtained for the study cohort were 40.79 ± 20.10, 47.79 ± 18.31 and 57.97 ± 11.70, respectively; total score of SF-36 plus KDCS was 51.12 ± 13.41 as well. The most common primary known disease was hypertension and the second etiology was diabetes. Ma-jority of patients were literate (53.4%) and married (72.7%). Only 10.1% of them were employed. Almost all patients were covered by insurance. The highest score for KDCS items was observed for dialysis staff encouragements (81.30 ± 21.87) and the lowest score was on work status (22.30 ± 34.56). The mean score of all domains, including SF-36 (8 items) and KDCS (11 items), was higher in male pa-tients. The KDCS-SF (SF-36 and KDCS) domain scores and the laboratory data are shown in Tables 1 and Table 4.
We found that 59% of our patients were anemic with he-moglobin level less than 10 g/dL for women and less than 11 g/dL for men; in 36.5% of cases the percent transferrin saturation (TSAT, i.e., = [serum iron ([micro]g/dL)/TIBC ([micro]g/dL)] × 100) was less than 20% and the serum fer-
ritin level was less than 200 μg/L in 21% of subjects. Only 14% of patients were adequately dialyzed with Kt/V more than 1.2. Calcium-phosphorus (Ca × P) product less than 55 and PTH concentrations between 150 and 300 pg/mL were seen in 68% and 23% of subjects, respectively. Low serum albumin level (less than 4.0 g/dL) was observed in only 30% of patients; thus, the higher percentage of our dialysis patients had an adequate serum albumin level. Table 3 summarizes the mean level of all laboratory data. 
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Table 2. Similar Researches Enrolled in Pooling Data 
Reference Year Sample 
Size
Mean Age M/Fa% Country PCSa MCSa KDCSa
(8) 2005 -2010 252 60.2 ± 15.5 65.9/35.1 Norwegian 36.6 ± 10.4 47.3 ± 11.0(21) 2011 202 52.5 ± 15.9 55.6/44.4 Brazil 42.2 ± 9.9 45.6 ± 14.6(5) 2006 -2007 223 69.5 ± 7.1 56.5/43.5 Brazil 38.28 ± 9.11 41.45 ± 9.88 69.27 ± 11.82(22) 1995 -1998 949 57.7 ± 14.8 54.1/46.9 United States. 32.7 ± 10.0 46.6 ± 11.6(1) 2004 -2008 183 56.7 ± 15.9 56.3/44.7 Lithuania 40.6 ± 18.9 48.9 ± 19.7(23) 1997 - 2007 1010 63.2 ± 13.8 56.7/44.3 Netherlands 38.8 ± 9.7 43.7 ± 11.3(4) 2009 709 51.7 ± 12.6 54.7/46.3 Romania 46.3 ± 19.2 55.1 ± 19.3 68.3 ± 11.3(10) 2006 27,154 61.5 ± 14.8 43/47 North America 33.2 ± 10.6 48.2 ± 11.2(24) 1995 - 2000 1,813 57.6 44/56 United States 35.75 ± 10.03 49.9 ± 10.89(25) 2006 71 59 ± 16 76/24 Denmark. 36.0 ± 10.2 51.1 ± 10.8 60.0 ± 19.8(26) 1996 -2004 9,526 59.5 ± 14.8 58/42 DOPPS 35.7 ± 10.7 44.6 ± 11.9(27) 2004 -2005 112 55.5 ± 16.9 42/58 USA 36.2 ± 9.8 47.7 ± 11.0 62.2 ± 25.3(28) 1996 -1997 1679 61.3 ------- United States 31.34 ± 9.7 44.32 ± 12.2(29) 2005 150 58.7 (18.21) 49.5/50.5 Irish 38.71 ± 10.08 51.12 ± 7.14(30) 1997 17,236 60.5 ± 15.2 57.4/43.6 DOPPSa 35.3_10.8 44.9 ± 11.9 63.5_13.0(20) 2006 -2007 170 51.76 ± 18.37 58.9/42.1 Iran 39.4 ± 21.6 41.6 ± 20.9 52.6 ± 13.5(31) 2009 100 53.4 ± 10.3 68.7/32.3 Saudi Arabia 52.7 ± 23.4 54.1 ± 24.5 59.7 ± 15.8(32) 2011 78 52.35 ± 13.53 77/33 India 36.29 ± 12.25 33.29 ± 4.91Our study 2010 - 2011 6969 54.4 ± 17.13 56.8/44.2 Iran 40.79 ± 20.12 47.79 ± 18.31 57.97 ± 11.7a Abbreviations: DOPPS; dialysis outcomes and practice patterns study, M/F; male/female, KDCS; kidney disease component summary, MCS; mental component summary, PCS; physical component summary
Table 3. Demographic and Laboratory Information 
Variables No. (%)
Cause of ESRD, No. (%)Hypertension 2109 (31.9)Diabetes 1689 (25.5)ADPKD 300 (4.5)SLE 168 (2.5)Infection 370 (5.6)Others 774 (11.7)Unknown 1202 (18.2)
Educational State, No. (%)Uneducated 2603 (47.6)Primary school 1475 (27)High school 1193 (21.8)University 202 (3.7)
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Gender, No. (%)Male 3897 (56.8)Female 2961 (43.2)
Age, No. (%)
≤ 45 1882 (28.6)46 - 60 2089 (31.7)> 60 2617 (39.7)
Nationality, No. (%)Iranian 6506 (96)Non-Iranian 269 (4)
Marital Status, No. (%)Un-married 784 (11.7)Married 4892 (72.7)Widowed/Divorced 1051 (15.6)
Work status, No. (%)Employment 678 (10.1)Unemployment 2622 (39)Retired 1257 (18.7)House keeper 2103 (31.2)Student 71 (1.1)
Age, y, mean ± SD 54.4 ± 17.13
Urea reduction ratio (URR), mean ± SD 57 ± 0.14
KT/V, mean ± SD 0.9 ± 0.3
Creatinine mg/dL, mean ± SD 8.9 ± 3.3
Sodiummmol/L, mean ± SD 138.7 ± 4.59
Potassiummmol/L, mean ± SD 5.1 ± 0.81
Calciummg/dL, mean ± SD 9 ± 1.1
Phosphorus mg/dL, mean ± SD 5.6 ± 1.6
Calcium phosphorus products, mean ± SD 50.2 ± 15.9
PTH pg/mL, mean ± SD 417 ± 470 (10-3395)
Alkaline phosphatas IU, mean ± SD 379.65 ± 338.4 (10-5171)
Hemoglubin g/dL, mean ± SD 10.1 ± 1.8
Serum ironμg/dL, mean ± SD 90.1 ± 90.6
Total iron binding capacity (TIBC) μg/dL, mean ± SD 28.07 ± 17.07
Transferin saturation (serum iron/TIBC) %, mean ± SD 28.07 ± 17.07
Ferritin ng/mL, mean ± SD 747.65 ± 785.8 (320-5730)
Triglyceride mg/dL, mean ± SD 164.4 ± 98.9
Cholesterol mg/dL, mean ± SD 159.1 ± 45.06
Low density lipoprotein (LDL) mg/dL, mean ± SD 83.5 ± 30.6
High density lipoprotein (HDL) mg/dL, mean ± SD 38.7 ± 11.46
Uric acid mg/dL, mean ± SD 6.9 ± 1.8
Albuming/dL, mean ± SD 4.2 ± 0.64
Aspartate aminotransferase (AST) IU/L, mean ± SD 21.08 ± 23.05
Alanine aminotransferase (ALT) IU/L, mean ± SD 21.31 ± 30.85
Prothrombin time second, mean ± SD 14 ± 5.4
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The elderly patients had significantly lower scores of all quality of life scales, except for social supports that no significant difference was observed. Staff encourage-ments was significantly better among middle-aged pa-tients (45-60 years old) (P = 0.006) and patients' satisfac-tion was significantly increased with age (P < 0.001).The higher educational level was significantly associated with better scores on all domains except the quality of social interactions that was abruptly decreased in patients with ac-ademic education (P≤ 0.001). In addition, dialysis staff en-couragement and patients' satisfaction decreased with high educational level (P = 0.002 and P≤ 0.001, respectively).
4.1. PCS ScoreIn this study, the patients’ PCS average score was low (below 43) in 61 % of patients. Higher PCS score was sig-nificantly associated with non-anemic patients (41.84 ± 20.37 vs. 40.29 ± 19.77, P = 0.004), calcium-phosphorus (Ca × P) product less than 55 (41.34 ± 20.46 vs. 40.14 ± 19.2, P = 0.03), and male gender (42.5 ± 20.6 vs. 38.5 ± 19.1, P≤ 0.001). There was a positive correlation between PCS score and serum albumin level (r = 0.12, P≤ 0.001), serum creatinine concentration (r = 0.08, P≤ 0.001), but weaker correlations with plasma sodium (r = 0.04, P = 0.001); on the other hand, a negative correlation was seen between PCS score and dialysis duration (r = -0.04, P = 0.001) and serum ferritin level (r = -0.064, P = 0.008).After adjusting for covariates (including cause of dis-ease, education, gender, age, hemoglobin, creatinine, plasma sodium, serum ferritin and albumin), only gen-der (B = 0.7, EXP B = 2.1, P≤ 0.001) and age (B = -0.3, EXP B = 0.9, P≤ 0.001) were the significant correlates of a PCS score more than 43.
4.2. MCS ScoreThe MCS score was less than 50 in 58.8% and less than 43 in 44.7% of patients. A significant association was seen be-tween MCS score and males (48.65 ± 19.02 vs. 46.65 ± 17.26, P≤ 0.001). In addition, a positive correlation was found be-tween MCS score and hemoglobin level (r = 0.06, P ≤ 0.001), serum albumin value (r = 0.09, P≤ 0.001), PTH concentra-tion (r = 0.09, P = 0.01), serum creatinine level (r = 0.04, P≤ 0.001), and plasma sodium (r = 0.04, P = 0.001); however, a negative correlation was observed between MCS score and serum ferritin level (r = -0.06, P = 0.004).After adjustment for covariates (including the cause of dis-ease, education, gender, age, sodium, PTH, serum ferritin, serum albumin and calcium-phosphorus (Ca × P) product), only age (B = -0.02, EXP B = 0.98, P = 0.04) and hemoglobin level (B = 0.1, EXP B = 1.1, P = 0.01) were significantly associ-ated with MCS score of more than 43. In addition, hemoglo-bin level (B = 0.02, EXP B = 1.2, P = 0.007) was only associated with MCS score of more than 51, after adjustment for covari-ates including the disease cause , education, gender, age, 
sodium, PTH, serum ferritin, serum albumin and anemia.
4.4. KDCS ScoreA KDCS score more than 50 was observed in 76.6% of participants. It was significantly associated with gender (male) (58.53 ± 12.07 vs. 57.21 ± 11.10, P≤ 0.001). Moreover, hemoglobin level (r = 0.05, P≤ 0.001), serum ferritin con-centration (r = 0.1, P≤ 0.001), serum albumin value (r = 0.06, P≤ 0.001), PTH level (r = 0.09, P = 0.01), serum cre-atinine amount (r = 0.03, P = 0.01), and plasma sodium (r = 0.04, P = 0.001) had a significant correlation with KDCS, while a negative correlation was found between KDCS score and dialysis duration (r = -0.08, P≤ 0.001).After adjustment for covariates (including cause of dis-ease, education, age, PTH, serum ferritin, serum albumin, dialysis duration, marital status and Kt/V), hemoglobin level (B = 0.02, EXP B = 1.2, P = 0.04) was only associated with KDCS score more than 50.
4.5. Outcome (Hospitalization)The frequency of hospitalization was 50.2% (3504 patients) and median length of stay in hospital was 7 (1- 105) days. All scores of PCS, MCS and KDCS were higher in non-hospitalized patients compared to hospitalized patients (PCS, 38.64 ± 19.74 vs. 42.97 ± 20.27 P < 0.001; MCS, 46.10 ± 18.32 vs. 49.51 ± 18.14 P < 0.001; and KDCS, 57.22 ± 11.74 vs. 58.72 ± 11.72 P < 0.001).Using one level regression analysis, Kt/V between 1 and 1.2 and PCS, MCS and KDCS more than 50 were significantly as-sociated with lower rate of hospitalizations (Table 4). While in multilevel logistic regression, Kt/V ratio between 1 and 1.2 and PCS, KDCS more than 50 were associated with a signifi-cant reduction in the risk of hospitalization (Table 5). 
4.6. Pooled Results From Similar StudiesThe result of pooled data were summarized in Figures 1, 2,  3 and  and 4.
5. DiscussionThis national cross-sectional study shows the largest co-hort of  patients with ESRD on HD with QoL information reported from Iran. In the current study, we observed PCS and MCS scores were slightly higher than overall results that co me from pooled data from 19 different studies; conversely, KDCS score was slightly lower than overall re-sults. Based on several studies (25, 33, 34), Kt/V could not predict QoL in none of specific and non-specific compo-nents, we detected a U shape pattern for effect of Kt/V on hospitalization. On the other hand, the lowerrate of hos-pitalization was significantly observed in Kt/V between 1 and 1.2 and the amount lesser or more than this range as-sociated with higher hospitalization possibility. We iden-tified 3 potentially variables that represented the stron-gest association with hospitalization risk (PCS, KDCS and Kt/V ratio between 1 and 1.2).
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Table 4. One Level Regression for Hospitalization 
Variable OR P-value Random Effect (P-
value)
Confidence Interval
Calcium phosphorus 
products > 55
0.9 0.14 0.56 0.46-0.69
PTH level 150-300 pg/
mL
0.84 0.5 0.92 0.5-1.5
PTH level > 300 pg/mL 0.89 0.62
Fasting blood glucose, 
mg/dL
1.001 0.055 0.49 0.38-0.64
Serum iron, μg/dL 1.001 0.1 0.4 0.2-0.7
Triglyceride, mg/dL 1.0007 0.059 0.44 0.4-0.7
Cholesterol, mg/dL 1.0005 0.5 0.54 0.4-0.7
Transferin saturation 
(Iron/TIBC) (%)
0.99 0.25 0.41 0.24-0.7
Ferritin level, ng/mL 0.99 0.5 0.7 0.5-1.04
Low density lipopro-
tein (LDL), mg/dL
1.001 0.62 0.8 0.4-1.6
High density lipopro-
tein (HDL), mg/dL
0.99 0.52 0.8 0.4-1.6
Uric acid > 6 mg/dL 1.2 0.1 0.6 0.5-0.8
KDCSa> 50 0.7 < 0.001 0.5 0.4-0.6
PCSa 0.99 < 0.001 0.5 0.45-0.65
MCSa 0.99 < 0.001 0.53 0.44-0.64
PCS > 50 0.7 < 0.001 0.5 0.45-0.65
MCS > 50 0.82 < 0.001 0.53 0.44-0.64
SF-36 > 50 0.76 < 0.001 0.53 0.44-0.64
KDCS + SF-36 > 50 0.7 < 0.001 0.53 0.44-0.64
Hemoglobin level, 
g/dL
1.007 0.6 0.57 0.46-0.7
Age (y) 0.99 0.8 0.51 0.42-0.62
Anemia (Hemoglo-
bin < 10 and < 11 for 
female and male 
respectively)
0.95 0.4 0.54 0.46-0.7
Kt/V 1-1.2 0.69 < 0.001 0.46 0.33-0.63
Kt/V > 1.2 0.82 0.12a Abbreviations: KDCS; kidney disease component summary, MCS; mental component summary, PCS; physical component summary 
Table 5. Multilevel Regression Modeling for Hospitalization 
Mean ± SD P Value Relative Risk (Confidence 
Interval)
PCSa> 50 0.7 ± 0.06 < 0.001 0.45 (0.32-0.62)
KDCSa> 50 0.69 ± 0.07 0.001
Kt/V 1-1.2 0.7 ± 0.07 0.001
Kt/V > 1.2 0.83 ± 0.1 0.14a Abbreviations: KDCS; kidney disease component summary, PCS; physical component summary
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[1] Norwegian (2005-2010)
[2] Brazil (2011)
[3] Brazil (2006-2007)
[4] United States. (1995-1998)
[5]Lithuania (2004—2008)
[6] Netherlands (1997-2007)
[7] Romania (2009)
[8] North America (2006)
[9] United States (1995-2000)
[11] Denmark (2006)
[12] DOPPS (1996-2004)
[13] USA (2004-2005)
[14] United States (1996-1997)
[15] Irish (2005)
[16] DOPPS (1997)
[17] Iran (2006-2007)
[18] saudi arabia (2009)
[19] India (2011)
[Our study] Iran (2009-2010)
Overall (I-squared = 99.1%, p = 0.000)
NOTE: Weights are from random effects analysis
Study                                                                                                                                                                                                                                                     %
ID                                                                                                                                                                                                            ES (95% CI)                         Weight
-70.4                                                                0                                                                 70.4
60.20 (58.29, 62.11)
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57.70 (56.76, 58.64)
56.70 (54.40, 59.00)
63.20 (62.35, 64.05)
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55.50 (52.37, 58.63)
61.30 (60.56, 62.04)
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Figure 1. Overall Mean Age of Pooled Data
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Figure 2. Overall Mean PCS Score From Pooled Data
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Figure 3 . Overall Mean MCS Score From Pooled Data
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Figure 4. Overall Mean KDCS Score From Data
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According to pooling data, the patients in this study were younger than the patients in the 19 different studies (54.4 vs. 59.7). Since the prevalence of ESRD varies widely among different ethnic groups (35); for example, the south Asian population who live in United Kingdom and suffering from CKD has also a younger age than the indigenous white population (36). In addition, some risk factors of CKD such as diabetes and hypertension are more frequent in this population.Although about 59% of the patients were anemic, the mean age was 54 years old. So better PCS and MCS scores might be expected, because they can tolerate some non-specific aspects of physical and mental components, while reduced KDCS scores might be due to unsuitable state for dialysis adequacy predictors such as Kt/V, as al-most only ¼ of our patients had 1 - 1.2 Kt/V and more than 60% had Kt/V less than 1. Significant improvement has been described in the survival of patients with optimized dialysis adequacy, despite the fact that few studies have found a correlation between the dialysis adequacy, Kt/V and urea reduction rate (URR) indices with HRQoL (33).We conclude that hypertension and diabetes mellitus are the most common causes of ESRD among our HD pa-tients. In this study, hypertension was the commonest cause of ESRD, followed by diabetes; however the major-ity of studies indicate diabetes mellitus as the first etiol-ogy of ESRD (24, 37, 38). The third most common category (18%) is the 'unknown origin', similar to the other studies, there was a significant number of ESRD patients with unknown cause; they usually developed with advanced renal failure and small size kidneys on renal ultrasonog-raphy; therefore, their disorders could not confirm with renal biopsy (36).Although, evaluation of gender frequency among CKD patients, needs a systematic review and meta-analysis that is not aimed in our study, in contrast to HEMO study (24) but such as other studies (2, 5, 39) the prevalence of male patients were was higher than female. In addition, it may be considered that near all of KDCS scores were higher in male, as previously reported (4, 19, 20). It seems healthy behaviors and outlooks also vary among women and men (28). For example, based on previous studies some factors including perception of social support, reli-gious conviction, and spirituality which persuade health outlook were reported more in women than men. Also questions dependent on physical strength may be scored with different values in both gender (28), and Hicks et al. (28) revealed different insight about health status and treatment preferences among women and men (28). On the other hand, Seica et al. believe that difference between male and female in HRQOL may be explained by women’s multiple domestic tasks and responsibilities that, unlike men, they cannot circumvent (4) such as housekeeping and breeding children. Furthermore, women never been 
retired.In the present study similar to HEMO study (24), in uni-variate analysis only patients' satisfaction and dialysis staff encouragement were increased with the age. Al-though in the dialysis outcomes and practice patterns study (DOPPS), Lopes et al. (40) reported a low patient sat-isfaction score in Asian (Japanese) HD patients (66.7), our patients had slightly more satisfaction (69.01 ± 24.24). This difference could be due to cultural diversity between Iranian and Japanese patients.Similar to other studies (5, 40-42), the worst dimension of quality of lifewas the occupational status, whereas in majority of them cognitive function and quality of social interaction were the best items.In the current study, the effects of daily life, social sup-port satisfaction, sleep, sexual function, staff encourage-ment and satisfaction were higher in women; however, similar to Vasquez et al. study (43), in multivariate level, gender had no effect on HRQOL.Although a total score of HRQOL including MCS, PCS, and KDCS, and the majority of KDCS items (9/11) had a scale of 50 percent and more, but only ¼ of PCS and ½ of MCS items had more than 50 percent scale, which is rela-tively similar to Euro DOPPS and united state results (41). Moreover, we did not compare the results of SF- 36 with Iranian general population; low score for SF-36 indicating wide gap between these groups.
5.1. KDCS Score Figure 3 revealed the mean KDCS score of our study was less than the results obtain from Romania (68.3) (4), Sau-di Arabia (59.7) (42), DOPPS (61.7) (40), as well as US and Euro-DOPPS studies (63.7 and 62.7) (41). However, Mapes et al. (41) believe that KDCS may contributes to a more in-depth assessment of the HRQOL of HD patients, but the results suggest that it may be contributed to predictions of death and hospitalization when information about PCS and MCS is available and factors within the MCS and PCS can explain the associations between KDCS and out-comes. On the other hand, Lopes et al. (40) found that no significant difference was observed between Asians and Caucasian for the MCS and KDCS. 
5.2. MCS and PCS ScoresA few data are available concerning the quality of life among Iranian HD patients in general. Our study showed that the quality of life scores among Iranian HD pa-tients were compared to other studies (Figures 2, 3 and 4). About 35% of our HD patients had both PCS and MCS scores lower than the critical scores that were established by Lowrie et al. (3). Similar to the previous studies, MCS score of our patients was higher than PCS score due to dy-namic adaptation of patients to their chronic illness (4). The difference between MCS and PCS was almost the same 
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(+7) that reported by Seica et al. (4) and was higher than (+4.5) Turkmen study (2) and Braga (+3.17) (5)and lower than Lacson et al. (+15) (10) study and the study conduct-ed in Saudi Arabia (+1.5) (42). 
5.3. HospitalizationSimilar to Zhang et al. study (44), half of our patients were at least one time hospitalized during this study. Spending time in hospital was similar to the mean length of stay in European countries which varied between 8.7 days in the UK to 14.7 days in Germany (median length of stay varied from 4 to 10 days for these countries) (45). Kalantar-Zadeh et al. (25) reported that prospective hos-pitalizations of hemodialysis patients significantly cor-relate with the SF-36 total score and its two main dimen-sions. Our study showed an inverse association between HRQOL and hospitalization for all three components of the KDQOL-SF (i.e., MCS, PCS, and KDCS) but after adjust-ment for several risk factors of hospitalization this as-sociations statistically remained significant just for the PCS and KDCS scores more than 50. It is important to note that, according to the results of this study, the associa-tions between hospitalization and dialysis adequacy had a U shape pattern (23).
5.4. LimitationThere are no HRQOL data were obtained in general pop-ulation and CKD individuals in Iran. Therefore, we could not compare the quality of life in HD patients with the general population and CKD cases. The mortality rate of ESRD patients was unrevealed, so we could not evaluate the correlation between survival and HRQOL.
5.5. ConclusionThis study showed that PCS and MCS scores were slight-ly more than the overall results while KDCS was slightly less than the overall results. In addition, dialysis adequa-cy with Kt/V between 1 and 1.2 is associated with a lower rate of hospitalization.
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